TO STUDY EFFECT OF ABHAYADI GHANAWATI COMPARED TO TABLET RANITIDINE IN MANAGEMENT OF URDHVAG AMLAPITTA
- Conditions
- Acute gastritis,
- Registration Number
- CTRI/2025/05/086844
- Lead Sponsor
- SELF
- Brief Summary
A Randomised Comparative Clinical Trial will be done and patients will be selected in two groups as per the inclusion criteria
Administration of the drug will be for 30 days for Group A and Group B
Followup will be taken at an interval of 7days for 2 weeks
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 35
patients having signs and symptoms of urdhvag amlapitta as described in ayurvedic samhitas that is chardi,amlodgar,hrullas,hruda kantadaha,udarda,shirashool,hastapada daha,aruchi,maddalotpatti.
patients suffering gastric ulcers, duodenal ulcers pregnant and lactating women CA stomach,oesophagus,esophageal varices, hematemesis patients having hepatic and renal disorders immunocompromised patients,blood coagulation systemic diseases like HTN,TB,DM.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 4 weeks ABHAYADI GHANAWATI IS EFFECTIVE IN URDHVAG AMLAPITTA
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Institute
🇮🇳Pune, MAHARASHTRA, India
Research Institute🇮🇳Pune, MAHARASHTRA, IndiaRUPALI KHOBRAGADEPrincipal investigator08378929859khobragaderupali19@gmail.com